David Greenberg Sells 2,424 Shares of ICU Medical (NASDAQ:ICUI) Stock

ICU Medical, Inc. (NASDAQ:ICUI) Director David Greenberg sold 2,424 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $122.91, for a total value of $297,933.84. Following the completion of the transaction, the director owned 7,960 shares of the company’s stock, valued at $978,363.60. The trade was a 23.34% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

ICU Medical Trading Up 0.8%

ICUI stock opened at $122.99 on Friday. ICU Medical, Inc. has a 1-year low of $107.00 and a 1-year high of $160.29. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.34 and a quick ratio of 1.17. The company has a market capitalization of $3.07 billion, a price-to-earnings ratio of 66.48, a PEG ratio of 1.76 and a beta of 0.74. The business has a 50 day simple moving average of $126.39 and a two-hundred day simple moving average of $138.44.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings results on Thursday, May 7th. The medical instruments supplier reported $1.97 earnings per share for the quarter, topping the consensus estimate of $1.78 by $0.19. ICU Medical had a return on equity of 7.50% and a net margin of 2.15%.The business had revenue of $525.77 million during the quarter, compared to the consensus estimate of $520.65 million. During the same period in the prior year, the company posted $1.72 EPS. The firm’s revenue for the quarter was down 12.3% compared to the same quarter last year. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. Research analysts anticipate that ICU Medical, Inc. will post 6.31 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the company. Wall Street Zen upgraded ICU Medical from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. KeyCorp dropped their price target on ICU Medical from $180.00 to $164.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. Weiss Ratings upgraded ICU Medical from a “sell (d)” rating to a “sell (d+)” rating in a research note on Monday. Piper Sandler dropped their price target on ICU Medical from $178.00 to $163.00 and set an “overweight” rating for the company in a research note on Friday, April 17th. Finally, Jefferies Financial Group upgraded ICU Medical to a “strong-buy” rating in a research note on Thursday, May 7th. Two analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $169.00.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of ICUI. AQR Capital Management LLC boosted its position in shares of ICU Medical by 2.5% during the 1st quarter. AQR Capital Management LLC now owns 9,360 shares of the medical instruments supplier’s stock valued at $1,297,000 after acquiring an additional 229 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of ICU Medical by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 12,764 shares of the medical instruments supplier’s stock valued at $1,772,000 after acquiring an additional 560 shares during the last quarter. United Services Automobile Association bought a new position in shares of ICU Medical during the 1st quarter valued at approximately $218,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of ICU Medical by 32.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 68,211 shares of the medical instruments supplier’s stock valued at $9,472,000 after acquiring an additional 16,680 shares during the last quarter. Finally, Intech Investment Management LLC boosted its position in shares of ICU Medical by 38.6% during the 1st quarter. Intech Investment Management LLC now owns 11,938 shares of the medical instruments supplier’s stock valued at $1,658,000 after acquiring an additional 3,326 shares during the last quarter. 96.10% of the stock is currently owned by institutional investors.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.